potential to attract a larger range of customers;
regional growth in the EU countries and the
“green” transformation of production, processing
of raw materials and further production of
finished products.
Bibliographic references
Bamel, N., Pereira, V., Bamel, U., &
Cappiello, G. (2021). Knowledge
management within a strategic alliances
context: past, present and future. Journal of
Knowledge Management, 25(7).
Barney, J. (1991). Firm resources and sustained
competitive advantage. Journal of
management, 17(1), 99‒120.
Chen, H., & Chen, T. J. (2003). Governance
structures in strategic alliances: transaction
cost versus resource-based perspective.
Journal of world business, 38(1), 1‒14.
Comino, S., Manenti, F. M., & Parisi, M. L.
(2007). From planning to mature: On the
success of open source projects. Research
policy, 36(10), 1575‒1586.
European Commission (2022). Industrial
alliances. Recovered from
https://ec.europa.eu/growth/industry/strategy
/industrial-alliances_en
Faber, J., Castaldi, C., & Muskens, R. W. (2016).
Venture capitalist-induced relational fit and
new venture performance: a Dutch biotech
comparative case analysis. Venture Capital,
18(3), 237‒256.
Gomez, J. R. (2015). Strategic Alliances:
Strategy of the Future. Touro Accounting &
Business Journal, 13. Recovered from
https://las.touro.edu/media/schools-and-
colleges/lander-college-for-arts-and-
sciences/documents/tab-
journals/tab_journal_spring_2015.pdf#page
=14
Grupa Azoty Zakłady Azotowe “Pulawy” S. A.
(2022). Official site. Recovered from
https://pulawy.grupaazoty.com
Harada, Y., Wang, H., Kodama, K., &
Sengoku, S. (2021). Drug Discovery Firms
and Business Alliances for Sustainable
Innovation. Sustainability, 13(7), 3599.
https://doi.org/10.3390/su13073599
Hellmann, T., & Puri, M. (2002). Venture capital
and the professionalization of start‐up firms:
Empirical evidence. The journal of finance,
57(1), 169‒197.
Higgins, M. J. (2007). The allocation of control
rights in pharmaceutical alliances. Journal of
Corporate Finance, 13(1), 58‒75.
Hretcanu, C. I., & Hretcanu, C. E. (2016).
Strategic alliances between firms – a model
of competitive strategy in food industry. Food
and Environment Safety Journal, 14(2).
HyProMag Limited Company (2022). Official
site. Recovered from https://hypromag.com
Kazakova, N., Shemetkova, O., Chemarina, A.,
& Melnik, M. (2018). Analysis Of
Effectiveness Of Companies Participation In
International Strategic Alliances.
International E-Journal of Advances in Social
Sciences, 4(11), 221‒228.
Lavie, D. (2006). The competitive advantage of
interconnected firms: An extension of the
resource-based view. Academy of
management review, 31(3), 638‒658.
Lazonick, W., & Tulum, Ö. (2011). US
biopharmaceutical finance and the
sustainability of the biotech business model.
Research Policy, 40(9), 1170‒1187.
Li, D., Eden, L., Hitt, M. A., Ireland, R. D., &
Garrett, R. P. (2012). Governance in
multilateral R&D alliances. Organization
Science, 23(4), 1191‒1210.
Liebeskind, J. P., Oliver, A. L., Zucker, L. G., &
Brewer, M. B. (1994). Social Networks,
Learning, and Flexibility: Sourcing Scientific
Knowledge in New Biotechnology.
Biotechnology Studies, Institute for Social
Science Research, UC Los Angeles, Vol. VI,
1994-95. Recovered from
https://bit.ly/3RrkKzx
Mamédio, D., Rocha, C., Szczepanik, D., &
Kato, H. (2019). Strategic alliances and
dynamic capabilities: A systematic review.
Journal of Strategy and Management, 12(1).
Marin, A., Hadar, A., Zapciu, M., & Purcarea,
A. A. (2015, October). Innovation alliances
in a knowledge based economy case study:
Romanian alliance for innovation in green
energy and sustainable products. In
International Conference on Management
and Industrial Engineering (No. 7, p. 33).
Niculescu Publishing House.
McCutchen Jr, W. W., & Swamidass, P. M.
(2004). Motivations for strategic alliances in
the pharmaceutical/biotech industry: Some
new findings. The Journal of High
Technology Management Research, 15(2),
197‒214.
Mkango Resources Ltd. (2022). Official site.
URL:
https://www.mkango.ca/projects/overview/
Nicholson, S., Danzon, P. M., &
McCullough, J. S. (2002). Biotech-
pharmaceutical alliances as a signal of asset
and firm quality. National Bureau of
Economic Research. Recovered from
https://www.nber.org/papers/w9007
Ortiz-de-Urbina-Criado, M., Montoro-Sánchez, Á.,
& Mora-Valentín, E.-M. (2014). Impact of